Publications by authors named "A Chandna"
Article Synopsis
- Disaster mental health is an essential but overlooked issue in India, with primary care physicians (PCPs) playing a vital role in addressing these challenges after disasters.
- A KAP survey conducted among 324 PCPs in Karnataka revealed moderate knowledge, positive attitudes, but poor practical skills in disaster mental healthcare.
- The findings highlight a significant gap between theoretical knowledge and practical preparedness, indicating a need for training programs and government initiatives to enhance the readiness of PCPs in managing disaster-related mental health issues.
Cerebral visual impairment (CVI), the leading cause of bilateral visual impairment in children, is often characterized by visual acuity (VA) loss and higher visual function deficits (HVFDs). However, the relationship between VA loss and HVFDs remains unknown. A previous study using the Higher Visual Function Question Inventory (HVFQI) demonstrated that normal VA did not preclude HVFDs.
View Article and Find Full Text PDFIntroduction: Acute febrile illness (AFI), traditionally attributed to malaria, is a common reason for seeking primary healthcare in rural South and Southeast Asia. However, malaria transmission has declined while health workers are often poorly equipped to manage non-malarial AFIs. This results in indiscriminate antibiotic prescribing and care escalation, which promotes antibiotic resistance and may increase healthcare costs.
View Article and Find Full Text PDFBackground: Hydroxychloroquine (HCQ) has proved ineffective in treating patients hospitalised with Coronavirus Disease 2019 (COVID-19), but uncertainty remains over its safety and efficacy in chemoprevention. Previous chemoprevention randomised controlled trials (RCTs) did not individually show benefit of HCQ against COVID-19 and, although meta-analysis did suggest clinical benefit, guidelines recommend against its use.
Methods And Findings: Healthy adult participants from the healthcare setting, and later from the community, were enrolled in 26 centres in 11 countries to a double-blind, placebo-controlled, randomised trial of COVID-19 chemoprevention.